Pharmafile Logo

Lucid Group prepare for a transformative year with the appointment of a new Director of Corporate Development

- PMLiVE

Lucid Group is setting itself up for another stellar year with a new appointment to their senior leadership team. Rob Apollo has joined Lucid on a permanent basis as Director of Corporate Development.

Rob brings a wealth of experience in acquiring and integrating businesses, and also in supporting growing businesses and building infrastructure. Rob is totally aligned with the aspirations and culture of Lucid Group, having been on the board for the last 18 months, representing LDC, who made a minority investment in Lucid back in June 2017.

Rob’s appointment is part of Lucid’s wider growth strategy to acquire new capabilities, partnerships and companies to allow them to continually deliver industry-leading solutions for their clients and patients.

Rob commented, “I have seen the business continue to deliver best-in-class services to clients while maintaining market-leading organic growth. However, what really inspires me is Lucid’s purpose to help improve patients’ lives, which is at the heart of everything we do. I’m incredibly excited about what we’re going to achieve going forward. Let’s bring the magic.”

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Group’s new website is launched!

Lucid Group unveil new website...

He who dares wins

The benefits of including medical experts in your brand planning team

Does your medical education drive change in clinical practice?

How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid

Advance the way you work with your experts

Written by Jan Steele PhD, operations director, Lucid